Login / Signup
TPM4 acts as a potential predictor for the response to PD-1/PD-L1-inhibitor therapy in patients with glioblastoma.
Lirui Dai
Mahbub E Touhid
Peizhi Zhou
Shu Jiang
Published in:
Asian journal of surgery (2024)
Keyphrases
</>
risk assessment
mesenchymal stem cells